e.g. Tata motors, Reliance MF, 500570

Goldline Pharmaceutical Ltd.

544759  GLPL   Group (MT)

20 May,11:45
53.94 -2.83 (-4.99%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
    Download App
BSE  |  NSE
zoomZoomRefresh
Day
Wk
Mn
6Mn
Yr
Volume

21,000

Prev close

56.77

Day's H/L (Rs.)

53.94 - 53.94

52wk H/L (Rs.)

0.00 - 0.00

Mkt Cap (Rs. Cr)

51.79

Goldline Pharmaceutical Ltd.

InvestChart

Goldline Pharmaceutical Ltd. is not listed on NSE (View BSE)

Financial Results of Goldline Pharmaceutical Ltd.

(Rs. Crore)
Mar ' 25Mar ' 24
Sales28.0623.57
Operating profit5.834.30
Interest1.721.61
Gross profit4.112.69
EPS (Rs)4.107.84

See More >

Compare 'Goldline Pharmaceutical Ltd.' with other stocks

  • Sai Life Science Ltd.
  • 1,116.30
  • Compare
  • Sun Pharmaceutical Industries Ltd.
  • 1,905.20
  • Compare
  • Divi's Laboratories Ltd.
  • 6,833.05
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 1,331.40
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 4,394.50
  • Compare
  • Zydus Lifesciences Ltd.
  • 991.20
  • Compare
  • Max Healthcare Institute Ltd.
  • 1,058.55
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 8,021.10
  • Compare

Statements:

Balance Sheet  |  P&L  |  Cash Flow  |  Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Goldline Pharmaceutical Ltd. PERFORMANCE SNAPSHOT

If you had invested Rs.
in Goldline Pharmaceutical Ltd.,
  ago

You would have Rs. 000.00

Add to Portfolio

Report Card

PE Ratios
13.83
EPS (Rs.)
4.10
Sales (Rs. Cr)
Face Value (Rs.)
10
Net Profit Margin (%)
10.09
Last Bonus
Last Dividend (%)
Return on Average Equity
30.61

Frequently Asked Questions

Q: What is the current share price of Goldline Pharmaceutical Ltd.?

A: The current share price of Goldline Pharmaceutical Ltd. is ₹ 53.94 (for BSE as on 20 May,11:45). The 52-week range is ₹ 0.00 - 0.00. Prices are updated based on live market data.

Q: What is the market capitalization of Goldline Pharmaceutical Ltd.?

A: Goldline Pharmaceutical Ltd. has a market capitalization of ₹ 51.79 Cr, making it a company.

Q: What is the PE ratio of Goldline Pharmaceutical Ltd.?

A: The Price-to-Earnings (PE) ratio of Goldline Pharmaceutical Ltd. is 13.83, indicating its valuation relative to earnings.

Q: Is Goldline Pharmaceutical Ltd. a good investment?

A: Goldline Pharmaceutical Ltd. is considered based on its financial performance, sector outlook, and market conditions. Investors should evaluate fundamentals and consult financial advisors before investing.

Q: What are the latest financial results of Goldline Pharmaceutical Ltd.?

A: Goldline Pharmaceutical Ltd. has reported its latest annual results with revenue of ₹ 28.06 and net profit/loss of ₹ 2.83.

Close
Add Goldline Pharmaceutical Ltd. to your Portfolio
 
 
     
 
Close
Add Goldline Pharmaceutical Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback